Clin2
NCT07332429Possibly a fitNot yet recruiting

Alcovit for lowering blood alcohol levels

Alcohol DrinkingBlood Alcohol ContentHangover

This study tests an investigational product called Alcovit to see if it reduces blood alcohol concentration. It may help people who want to lower their blood alcohol levels after moderate drinking, but it is not intended for people with alcohol problems.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
228 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are a healthy adult aged 18 to 70.
  • You drink alcohol occasionally or moderately (not daily heavy drinking).
  • You can stop drinking alcohol and taking Alcovit for the length of the study.
  • You are willing to sign a consent form and follow the study schedule.
  • You do not have a history of alcoholism or drug abuse.
  • You are not taking medications that interact with alcohol, such as certain painkillers, antibiotics, antidepressants, or sedatives.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06722898Not yet recruiting· Phase 2
Supplement blend for faster alcohol breakdown in social drinkers

This trial tests a natural supplement blend to see if it can reduce blood alcohol levels faster after drinking. If you are a social drinker, you may be able to join and help find a way to help people sober up more quickly.

St. Petersburg, Florida
NCT05408247Recruiting· Phase 4
N-acetylcysteine to help people cut back on alcohol

This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.

Sydney, New South Wales
NCT03503708Not yet recruiting
Herbal supplement for liver function in alcoholic liver disease

This study tests whether a herbal supplement can improve liver function in people with alcoholic liver disease. If you have liver damage from alcohol but not severe cirrhosis, this supplement may help your liver recover.

Bangalore, Karnataka
NCT06613698Recruiting· Phase 2
Testing an investigational drug for alcohol-related liver disease

This trial tests whether a new drug, GSK4532990, is safe and effective compared to a placebo in adults aged 18 to 70 with liver disease caused by alcohol use. The study aims to see if the drug can help treat advanced chronic liver disease.

Chandler, Arizona
NCT07681869Not yet recruiting· Phase 2
Nimodipine for reducing alcohol drinking

This study tests if a blood-pressure medicine called nimodipine can help people who drink heavily reduce their alcohol intake. The trial involves lab-based drinking sessions and brain scans to understand how the drug works on the brain.

New Haven, Connecticut
NCT07118618Recruiting· Phase 2
Probenecid for alcohol cravings and drinking

This study tests if the medication probenecid can help reduce cravings for alcohol and the amount you drink. It is for people who drink heavily and have moderate to severe alcohol use disorder.

Providence, Rhode Island

Hear when a new Alcohol Drinking trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.